News

Technology News

Amgen And Novartis Partner With Atlas Venture

Friday, May 17, 2013 5:01:00 AM PDT | VentureDeal
Cambridge, MA  --  Life science technology companies Amgen and Novartis have concluded a Corporate Strategic Partnership with venture capital firm Atlas Venture.

The intent of the partnerships is to increase collaboration between the companies and the venture capital firm on potentially high-impact medicines.

The two companies also announced an investment in Atlas Venture's latest investment fund, Atlas IX.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1